On the midweek edition of the Morning Mail, David is joined by Head of Research at Evans and Partners, Lou Capparelli.We have recently initiated coverage of Pioneer Credit Ltd (PNC). Lou provides a synopsis of the key business operations, location,...

On the first edition of the Morning Mail for the week, David is joined by Chief Investment Officer at Evans and Partners, Mike Hawkins.Mike firstly discusses the March Quarter GDP announcement, running through the overall result as well as providing...

On the first edition of the Morning Mail for the week, David is joined by Chief Investment Officer at Evans and Partners, Mike Hawkins.Mike firstly discusses the March Quarter GDP announcement, running through the overall result as well as providing commentary on how the June quarter is playing out. Mike then comments on the recent export and import trends for China including robust iron ore imports. The European Central Bank’s decision to provide further policy stimulus, particularly with respect to the implications for global currency markets, is also highlighted.

This podcast is not intended to be a research report (as defined in ASIC Regulatory Guides 79 and 264). Any express or implicit opinion or recommendation about a named or readily identifiable investment product is merely a restatement, summary or extract of another research report prepared by Evans and Partners that has already been broadly distributed. You may obtain a copy of the original research report from an Evans and Partners Advisor. Please visit https://www.evansandpartners.com.au/important-disclosures to access important disclosures regarding Evans and Partners’ relationships

This podcast contains factual information or general advice and does not take into consideration any particular person’s financial situation, goals, needs or tolerance for risk. Before acting on the information, you should consider the appropriateness of it, having regard to your own particular financial situation, goals, needs or tolerance for risk and/or seek professional advice. Any forward looking statements are based on current expectations at the time of the interview. No assurance can be given that such expectations will prove to be correct.

The material contained in this document is for information purposes only and does not constitute an offer, solicitation or recommendation with respect to the purchase or sale of securities. It should not be regarded by recipients as a substitute for the exercise of their own judgment. If the material relates to a financial product that is the subject of a Product Disclosure Statement or offer document investors should obtain a copy of the relevant disclosure document and consider it before making any decision about whether to acquire the product. Readers should be aware that past performance should not be construed as an indication of future performance and that future returns are not guaranteed

Any opinions and/or recommendations expressed in this podcast are subject to change without notice and Evans and Partners is not under any obligation to update or keep current the information contained herein. References made to third parties are based on information believed to be reliable but are not guaranteed as being accurate.

On the final edition of the Morning Mail for the week, David is joined by Evans and Partners Research Analyst, Peter Stamoulis.Peter provides an overview across the various businesses of SEEK Ltd (SEK), talking to both the domestic and international...

On the final edition of the Morning Mail for the week, David is joined by Evans and Partners Research Analyst, Peter Stamoulis.Peter provides an overview across the various businesses of SEEK Ltd (SEK), talking to both the domestic and international asset base. Peter further discusses the upcoming float of Chinese company Zhaopin Ltd and the valuation impact for SEEK post-IPO before providing some ideas for investors thinking of including SEEK in their portfolio.

This podcast is not intended to be a research report (as defined in ASIC Regulatory Guides 79 and 264). Any express or implicit opinion or recommendation about a named or readily identifiable investment product is merely a restatement, summary or extract of another research report prepared by Evans and Partners that has already been broadly distributed. You may obtain a copy of the original research report from an Evans and Partners Advisor. Please visit https://www.evansandpartners.com.au/important-disclosures to access important disclosures regarding Evans and Partners’ relationships

This podcast contains factual information or general advice and does not take into consideration any particular person’s financial situation, goals, needs or tolerance for risk. Before acting on the information, you should consider the appropriateness of it, having regard to your own particular financial situation, goals, needs or tolerance for risk and/or seek professional advice. Any forward looking statements are based on current expectations at the time of the interview. No assurance can be given that such expectations will prove to be correct.

The material contained in this document is for information purposes only and does not constitute an offer, solicitation or recommendation with respect to the purchase or sale of securities. It should not be regarded by recipients as a substitute for the exercise of their own judgment. If the material relates to a financial product that is the subject of a Product Disclosure Statement or offer document investors should obtain a copy of the relevant disclosure document and consider it before making any decision about whether to acquire the product. Readers should be aware that past performance should not be construed as an indication of future performance and that future returns are not guaranteed

Any opinions and/or recommendations expressed in this podcast are subject to change without notice and Evans and Partners is not under any obligation to update or keep current the information contained herein. References made to third parties are based on information believed to be reliable but are not guaranteed as being accurate.

On the Thursday edition of the Morning Mail, Philip Anglin is joined by Head of Fixed Interest at Evans and Partners, Mike Saba.Mike provides an overview of recent interest rate changes, both globally and domestically, and their driving factors....

On the Thursday edition of the Morning Mail, Philip Anglin is joined by Head of Fixed Interest at Evans and Partners, Mike Saba.Mike provides an overview of recent interest rate changes, both globally and domestically, and their driving factors. With falling yields, investors are struggling to find value. Mike looks at an alternative to term deposits and well as some thoughts for buyers looking at investing in bonds in both the listed and unlisted space.

This podcast is not intended to be a research report (as defined in ASIC Regulatory Guides 79 and 264). Any express or implicit opinion or recommendation about a named or readily identifiable investment product is merely a restatement, summary or extract of another research report prepared by Evans and Partners that has already been broadly distributed. You may obtain a copy of the original research report from an Evans and Partners Advisor. Please visit https://www.evansandpartners.com.au/important-disclosures to access important disclosures regarding Evans and Partners’ relationships

This podcast contains factual information or general advice and does not take into consideration any particular person’s financial situation, goals, needs or tolerance for risk. Before acting on the information, you should consider the appropriateness of it, having regard to your own particular financial situation, goals, needs or tolerance for risk and/or seek professional advice. Any forward looking statements are based on current expectations at the time of the interview. No assurance can be given that such expectations will prove to be correct.

The material contained in this document is for information purposes only and does not constitute an offer, solicitation or recommendation with respect to the purchase or sale of securities. It should not be regarded by recipients as a substitute for the exercise of their own judgment. If the material relates to a financial product that is the subject of a Product Disclosure Statement or offer document investors should obtain a copy of the relevant disclosure document and consider it before making any decision about whether to acquire the product. Readers should be aware that past performance should not be construed as an indication of future performance and that future returns are not guaranteed

Any opinions and/or recommendations expressed in this podcast are subject to change without notice and Evans and Partners is not under any obligation to update or keep current the information contained herein. References made to third parties are based on information believed to be reliable but are not guaranteed as being accurate.

On the midweek edition of the Morning Mail, David is joined by Chief Executive Officer at Evans and Partners, Paul Ryan.Qube Holdings Ltd (QUB) and Aurizon Holdings Ltd (AZJ) have recently been given exclusive rights to negotiate with the Moorebank...

On the midweek edition of the Morning Mail, David is joined by Chief Executive Officer at Evans and Partners, Paul Ryan.Qube Holdings Ltd (QUB) and Aurizon Holdings Ltd (AZJ) have recently been given exclusive rights to negotiate with the Moorebank Intermodal Company about the development & operation of a freight terminal in western Sydney. Paul outlines the scope and potential capital requirements of the project as well as implications for valuation. Paul goes on to discuss the recent reaffirmation of FY14 guidance and business restructure planned by Toll Holdings Ltd (TOL).

This podcast is not intended to be a research report (as defined in ASIC Regulatory Guides 79 and 264). Any express or implicit opinion or recommendation about a named or readily identifiable investment product is merely a restatement, summary or extract of another research report prepared by Evans and Partners that has already been broadly distributed. You may obtain a copy of the original research report from an Evans and Partners Advisor. Please visit https://www.evansandpartners.com.au/important-disclosures to access important disclosures regarding Evans and Partners’ relationships

This podcast contains factual information or general advice and does not take into consideration any particular person’s financial situation, goals, needs or tolerance for risk. Before acting on the information, you should consider the appropriateness of it, having regard to your own particular financial situation, goals, needs or tolerance for risk and/or seek professional advice. Any forward looking statements are based on current expectations at the time of the interview. No assurance can be given that such expectations will prove to be correct.

The material contained in this document is for information purposes only and does not constitute an offer, solicitation or recommendation with respect to the purchase or sale of securities. It should not be regarded by recipients as a substitute for the exercise of their own judgment. If the material relates to a financial product that is the subject of a Product Disclosure Statement or offer document investors should obtain a copy of the relevant disclosure document and consider it before making any decision about whether to acquire the product. Readers should be aware that past performance should not be construed as an indication of future performance and that future returns are not guaranteed

Any opinions and/or recommendations expressed in this podcast are subject to change without notice and Evans and Partners is not under any obligation to update or keep current the information contained herein. References made to third parties are based on information believed to be reliable but are not guaranteed as being accurate.

On the Tuesday edition of the Morning Mail, David is joined by Lou Capparelli, Head of Research at Evans and Partners.Lou firstly analyses the Healthcare sector with specific reference to the removal of bulk-billing proposed in the recent federal budget and the impact on earnings and volumes for healthcare companies (Primary Health Care Ltd, Sonic Healthcare Ltd and Ramsay Health Care Ltd), that this change may trigger. Lou also shares his recommendation for the top healthcare stock investors should have in their portfolio.

This podcast is not intended to be a research report (as defined in ASIC Regulatory Guides 79 and 264). Any express or implicit opinion or recommendation about a named or readily identifiable investment product is merely a restatement, summary or extract of another research report prepared by Evans and Partners that has already been broadly distributed. You may obtain a copy of the original research report from an Evans and Partners Advisor. Please visit https://www.evansandpartners.com.au/important-disclosures to access important disclosures regarding Evans and Partners’ relationships

This podcast contains factual information or general advice and does not take into consideration any particular person’s financial situation, goals, needs or tolerance for risk. Before acting on the information, you should consider the appropriateness of it, having regard to your own particular financial situation, goals, needs or tolerance for risk and/or seek professional advice. Any forward looking statements are based on current expectations at the time of the interview. No assurance can be given that such expectations will prove to be correct.

The material contained in this document is for information purposes only and does not constitute an offer, solicitation or recommendation with respect to the purchase or sale of securities. It should not be regarded by recipients as a substitute for the exercise of their own judgment. If the material relates to a financial product that is the subject of a Product Disclosure Statement or offer document investors should obtain a copy of the relevant disclosure document and consider it before making any decision about whether to acquire the product. Readers should be aware that past performance should not be construed as an indication of future performance and that future returns are not guaranteed

Any opinions and/or recommendations expressed in this podcast are subject to change without notice and Evans and Partners is not under any obligation to update or keep current the information contained herein. References made to third parties are based on information believed to be reliable but are not guaranteed as being accurate.